Pregled bibliografske jedinice broj: 212646
S-Adenosylhomocysteine hydrolase deficiency: a second patient, the younger brother of the index patient, and outcomes during therapy
S-Adenosylhomocysteine hydrolase deficiency: a second patient, the younger brother of the index patient, and outcomes during therapy // Journal of Inherited Metabolic Disease, 28 (2005), 6; 885-902 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 212646 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
S-Adenosylhomocysteine hydrolase deficiency: a second patient, the younger brother of the index patient, and outcomes during therapy
(S-Adenosylhomocysteine hydrolase deficiency: a second patient, the younger brother of the index patient, and outcomes during therapy.)
Autori
Barić, Ivo ; Ćuk, Mario ; Fumić, Ksenija ; Vugrek, Oliver ; Allen, R.H. ; Glenn, Byron ; Maradin, Miljenka ; Pažanin, Leo ; Pogribny, Igor ; Radoš, Marko ; Sarnavka, Vladimir ; Schulze, Andreas ; Stabler, Sally ; Wagner, Conrad ; Zeisel, Steven H. ; Mudd, Harvey
Izvornik
Journal of Inherited Metabolic Disease (0141-8955) 28
(2005), 6;
885-902
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
S-adenosylhomocysteine hydrolase deficiency; treatment
Sažetak
S-Adenosylhomocysteine (AdoHcy) hydrolase deficiency has been proven in a human only once, in a recently described Croatian boy. Here we report the clinical course and biochemical abnormalities of the younger brother of this proband. This younger brother has the same two mutations in the gene encoding AdoHcy hydrolase, and has been monitored since birth. We report, as well, outcomes during therapy for both patients. The information obtained suggests that the disease starts in utero and is characterized primarily by neuromuscular symptomatology (hypotonia, sluggishness, psychomotor delay, absent tendon reflexes, delayed myelination). The laboratory abnormalities are markedly increased creatine kinase and elevated aminotransferases, as well as specific amino acid aberrations that pinpoint the etiology. The latter include, most importantly, markedly elevated plasma AdoHcy. Plasma S-adenosylmethionine (AdoMet) is also elevated, as is methionine (although the hypermethioninemia may be absent or non-significant in the first weeks of life). The disease seems to be at least to some extent treatable, as shown by improved myelination and psychomotor development during dietary methionine restriction and supplementation with creatine and phosphatidylcholine.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Marko Radoš
(autor)
Ivo Barić
(autor)
Leo Pažanin
(autor)
Miljenka Maradin
(autor)
Oliver Vugrek
(autor)
Vladimir Sarnavka
(autor)
Mario Ćuk
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE